The benzodiazepine binding site of GABAA receptors as a target for the development of novel anxiolytics

@article{Atack2005TheBB,
  title={The benzodiazepine binding site of GABAA receptors as a target for the development of novel anxiolytics},
  author={J. Atack},
  journal={Expert Opinion on Investigational Drugs},
  year={2005},
  volume={14},
  pages={601 - 618}
}
  • J. Atack
  • Published 2005
  • Medicine
  • Expert Opinion on Investigational Drugs
  • Non-selective benzodiazepine (BZ) binding-site full agonists, exemplified by diazepam, act by enhancing the inhibitory effects of GABA at GABAA receptors containing either an α1, -2, -3 or -5 subunit. However, despite their proven clinical anxiolytic efficacy, such compounds possess a relatively narrow window between doses that produce anxiolysis and those that cause sedation, and are also associated with physical dependence and a potential for abuse. In the late 1980s and early 1990s a number… CONTINUE READING
    151 Citations
    GABAA Receptor α2/α3 Subtype-Selective Modulators as Potential Nonsedating Anxiolytics
    • 41
    Development and SAR of functionally selective allosteric modulators of GABAA receptors.
    • 36
    A Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor Model
    • 29
    • PDF

    References

    SHOWING 1-10 OF 150 REFERENCES
    Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site.
    • J. Atack
    • Medicine, Biology
    • Current drug targets. CNS and neurological disorders
    • 2003
    • 131
    Novel anxiolytics that act as partial agonists at benzodiazepine receptors.
    • 219
    Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype
    • 856
    • Highly Influential
    Benzodiazepine recognition site ligands and GABAA receptors
    • 8
    Selective antagonists of benzodiazepines
    • 1,184
    α-Subunit selective modulators of GABAA receptor function as CNS therapeutics
    • 7
    Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
    • 1,013
    Benzodiazepines on trial: a research strategy for their rehabilitation.
    • 152
    Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors.
    • 82
    Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates.
    • 166
    • PDF